HealthEquity reported a slight revenue increase to $180.0 million, but experienced a net loss of $5.0 million, contrasting with a net income of $1.8 million in the same quarter last year. Non-GAAP net income was $28.9 million. The company saw a 14% increase in HSAs to 6.2 million and a 32% increase in total HSA assets to $16.4 billion. Key acquisitions of Fifth Third Bank HSA portfolio and Further were completed during and after the quarter.
Revenue increased slightly to $180.0 million, up less than 1% year-over-year.
Net loss was $5.0 million, a significant change from the $1.8 million net income in Q3 FY21.
Total HSAs grew by 14% to 6.2 million, with total HSA assets increasing by 32% to $16.4 billion.
Completed acquisition of Fifth Third Bank HSA portfolio and Further, adding a substantial number of new HSAs.
For the fiscal year ending January 31, 2022, HealthEquity anticipates revenues between $750 million and $755 million, a net loss between $36 million and $33 million, and non-GAAP net income between $108 million and $112 million. Adjusted EBITDA is expected to be between $230 million and $235 million. This outlook includes the impact of recent acquisitions and financing activities.
Visualization of income flow from segment revenue to net income